Healthpeak Properties, Inc. (DOC) SEC Filings & Earnings Calls

Labor cost inflation

“higher costs of labor, food, utilities, repairs and maintenance, operator management fees, and other operating expenses” · word for word

Interest rate exposure

“Interest expense increased for the three and six months ended June 30, 2026 primarily as a result of: (i) the issuance of $500 million aggregate principal amount of 4.75% senior unsecured notes due 2033” · word for word

Credit rating downgrade risk

“A downgrade in credit ratings by Moody’s or S&P Global may have a negative impact on (i) the interest rates of our Revolving Facility” · word for word

Lab occupancy decline

“End of period occupancy 88.3% (down from 97.9% a year ago)”

Interest expense increase

“Interest expense increased for the three months ended March 31, 2026 primarily as a result of: (i) the issuance of $500 million aggregate principal amount of 5.38% senior unsecured notes due 2035” · word for word

Increased debt capacity could lead to higher leverage if drawn, but no immediate risk.

“No default or event of default exists; terms are based on debt ratings.” · word for word

Lab sector supply/demand headwinds

“Questions about the impact of macroeconomic conditions and strategy to deal with supply and demand headwinds in the Lab sector” · word for word

Below-target LTIP payout indicates poor relative stock performance

“The 2023 LTIP, covering a three-year performance period from 2023 to 2025, paid out below the target level based on our TSR performance relative to objectively-defined peer indices.” · word for word

Ongoing tracking below target for 2024 and 2025 LTIP awards

“Tracking Below Target (Overall) for 2024 and 2025 Performance-Based Awards”

Healthcare policy and funding uncertainty

“Recent policy shifts and administration priorities affecting research funding, drug pricing, drug review and approval processes, and tariffs, among other policies, have created uncertainty in the life science ecosystem in which our lab tenants operate.” · word for word

Lab tenant funding risk

“If venture capital firms, private investors, the public markets, companies in the life science industry, the government, or other sources of funding are difficult to obtain or unavailable to support our tenants' activities, our tenants' business would be adversely affected or could fail.” · word for word

Senior housing operational risk via RIDEA

“Under a RIDEA structure, our TRS is ultimately responsible for all operational risks and other liabilities of the properties.” · word for word

Lab segment occupancy decline

“End of period occupancy (4) 93.2% │ 97.7% (lab same-store occupancy down 450bps YoY)” · word for word

Impairment charges on lab joint ventures

“Equity income (loss) from unconsolidated joint ventures decreased for the three and nine months ended September 30, 2025 primarily as a result of other-than-temporary impairment charges on two lab unconsolidated joint ventures” · word for word

Interest expense increase

“Interest expense increased for the three months ended September 30, 2025 primarily as a result of: (i) the issuance of $500 million aggregate principal amount of 5.38% senior unsecured notes due 2035, (ii) the issuance of $500 million aggregate principal amount of 4.75% senior unsecured notes due 2033, and (iii) higher borrowings under the commercial paper p” · word for word

Credit rating downgrade risk

“A downgrade in credit ratings by Moody’s or S&P Global may have a negative impact on (i) the interest rates of our Revolving Facility, 2027 Term Loans, 2028 Term Loan, and 2029 Term Loan, (ii) facility fees for our Revolving Facility, and (iii) the pricing of notes issued under our commercial paper program and senior unsecured notes.” · word for word